Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quezada

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Nature|February 19, 2025
GABAergic neuron-to-glioma synapses in diffuse midline gliomasTara Barron, Belgin Yalçın, Minhui Su, et al.
The Lancet Regional Health. Europe|April 14, 2025
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trialAurora Páez-Vega, José M Vaquero-Barrios, Elisa Ruiz-Arabi, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Journal for Immunotherapy of Cancer|March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomasE Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
Nature Communications|February 5, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myelomaKane A Foster, Elise Rees, Louise Ainley, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Nature|February 19, 2025
GABAergic neuron-to-glioma synapses in diffuse midline gliomasTara Barron, Belgin Yalçın, Minhui Su, et al.
The Lancet Regional Health. Europe|April 14, 2025
Safety and efficacy of immunoguided prophylaxis for cytomegalovirus disease in low-risk lung transplant recipients in Spain: a multicentre, open-label, randomised, phase 3, noninferiority trialAurora Páez-Vega, José M Vaquero-Barrios, Elisa Ruiz-Arabi, et al.
Journal of Translational Medicine|July 1, 2021
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy)Paolo A Ascierto, Christian Blank, Reinhard Dummer, et al.
Journal for Immunotherapy of Cancer|March 6, 2019
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomasE Dodagatta-Marri, D S Meyer, M Q Reeves, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Cell Reports|July 19, 2018
ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 PresentationJames Monypenny, Hanna Milewicz, Fabian Flores-Borja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES StudyGianmarco Leone, Yien Ning Sophia Wong, Robert J Jones, et al.
Nature Communications|February 5, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myelomaKane A Foster, Elise Rees, Louise Ainley, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Pageof 24